WHO ICTRP trial

Clinical trial for identification of safety dose of coffee cherry concentrate in…

TCTR20220927004 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20220927004
Public title Clinical trial for identification of safety dose of coffee cherry concentrate in healthy volunteers
Scientific title Clinical trial for identification of safety dose of coffee cherry concentrate in healthy volunteers
Primary sponsor Mivana Company Limited
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries Thailand
Conditions safety study healthy volunteers consumer product safety dose, maximum tolerated beverages and food coffee ;consumer product safety dose, maximum tolerated beverages and food coffee
Interventions Coffee cherry concentrate beverage was given to participants in a dose-escalation manner. There were two phases. In the single-ascending phase, six subjects received a single dose daily in a stepwise escalation from 1 to 14 g of coffee…
Registration date Sep 27, 2022
Target size 18
Secondary IDs Nil Known
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations